carvedilol has been researched along with Electrocardiogram QT Prolonged in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the efficacy of carvedilol for preventing the recurrence of atrial fibrillation and reducing QT prolongation induced by bepridil." | 9.17 | Carvedilol is effective and safe in combination with bepridil for persistent atrial fibrillation and decreases the QT prolongation induced by bepridil therapy. ( Kawamura, M; Kobayashi, Y; Munetsugu, Y; Tanno, K, 2013) |
| "To evaluate effects of carvedilol (Akridilol, AKRIKHIN, Russia) on central hemodynamics, microvascular bed, hemorheology, von Willebrand factor (VWF) activity, clinical efficacy of the drug and influence on exercise tolerance in patients with Q myocardial infarction (QMI) compared to therapy with atenolol." | 9.11 | [Carvedilol in combined therapy of patients with Q myocardial infarction]. ( Iakovleva, MS; Mironova, MA; Sadionchenko, VS; Shekhian, GG, 2005) |
| "We investigated the efficacy of carvedilol for preventing the recurrence of atrial fibrillation and reducing QT prolongation induced by bepridil." | 5.17 | Carvedilol is effective and safe in combination with bepridil for persistent atrial fibrillation and decreases the QT prolongation induced by bepridil therapy. ( Kawamura, M; Kobayashi, Y; Munetsugu, Y; Tanno, K, 2013) |
| "To evaluate effects of carvedilol (Akridilol, AKRIKHIN, Russia) on central hemodynamics, microvascular bed, hemorheology, von Willebrand factor (VWF) activity, clinical efficacy of the drug and influence on exercise tolerance in patients with Q myocardial infarction (QMI) compared to therapy with atenolol." | 5.11 | [Carvedilol in combined therapy of patients with Q myocardial infarction]. ( Iakovleva, MS; Mironova, MA; Sadionchenko, VS; Shekhian, GG, 2005) |
| "Carvedilol pretreatment is associated with a reduction in both the QTd and LF/HF ratio, raising the possibility that the cardiac sympathovagal balance shift may be responsible for the impaired homogeneity of myocardial repolarization, and that beta-blocker pretreatment may decrease the mortality risk during alcoholic withdrawal." | 1.36 | QT interval dispersion and cardiac sympathovagal balance shift in rats with acute ethanol withdrawal. ( Fujimiya, T; Hamada, K; Liu, J; Okamura, N; Shirafuji, S, 2010) |
| "Carvedilol has a class III antiarrhythmic effect, which may provide the rationale for a favourable clinical outcome compared with other beta-blockers as suggested in the recent COMET (Carvedilol Or Metoprolol European Trial) substudy." | 1.33 | Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy. ( Abe, H; Anson, BD; Delisle, BP; January, CT; Kawakami, K; Kikuchi, K; Nagatomo, T; Nakashima, Y; Takemasa, H, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bankston, JR | 1 |
| Kass, RS | 1 |
| Shirafuji, S | 1 |
| Liu, J | 1 |
| Okamura, N | 1 |
| Hamada, K | 1 |
| Fujimiya, T | 1 |
| Mah, D | 1 |
| Wang, A | 1 |
| Wu, A | 1 |
| Alexander, ME | 1 |
| Walsh, EP | 1 |
| Maruyama, M | 1 |
| Xiao, J | 1 |
| Zhou, Q | 1 |
| Vembaiyan, K | 1 |
| Chua, SK | 1 |
| Rubart-von der Lohe, M | 1 |
| Lin, SF | 1 |
| Back, TG | 1 |
| Chen, SR | 1 |
| Chen, PS | 1 |
| Li, N | 1 |
| Wehrens, XH | 1 |
| Kawamura, M | 1 |
| Munetsugu, Y | 1 |
| Tanno, K | 1 |
| Kobayashi, Y | 1 |
| Etheridge, SP | 1 |
| Shaddy, RE | 1 |
| Sadionchenko, VS | 1 |
| Iakovleva, MS | 1 |
| Shekhian, GG | 1 |
| Mironova, MA | 1 |
| Kawakami, K | 1 |
| Nagatomo, T | 1 |
| Abe, H | 1 |
| Kikuchi, K | 1 |
| Takemasa, H | 1 |
| Anson, BD | 1 |
| Delisle, BP | 1 |
| January, CT | 1 |
| Nakashima, Y | 1 |
2 trials available for carvedilol and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
Carvedilol is effective and safe in combination with bepridil for persistent atrial fibrillation and decreases the QT prolongation induced by bepridil therapy.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzimidazoles; Bepridil; Biphenyl Compounds; Car | 2013 |
[Carvedilol in combined therapy of patients with Q myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Atenolol; Carbazoles; Carvedilol; Drug | 2005 |
7 other studies available for carvedilol and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
Molecular determinants of local anesthetic action of beta-blocking drugs: Implications for therapeutic management of long QT syndrome variant 3.
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Carbazoles; Carvedilol; Cell Line; Electrophysiolog | 2010 |
QT interval dispersion and cardiac sympathovagal balance shift in rats with acute ethanol withdrawal.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alcohol Drinking; Animals; Carbazoles; Ca | 2010 |
Marked QT prolongation and ventricular tachycardia of a transient nature in young children with cardiomyopathy.
Topics: Carbazoles; Cardiomyopathies; Cardiotonic Agents; Carvedilol; Child; Electrocardiography; Humans; In | 2012 |
Carvedilol analogue inhibits triggered activities evoked by both early and delayed afterdepolarizations.
Topics: Action Potentials; Analysis of Variance; Animals; Calcium; Carbazoles; Carvedilol; Heart Ventricles; | 2013 |
Extinguishing intracellular calcium leak: a promising antiarrhythmic approach.
Topics: Animals; Carbazoles; Carvedilol; Long QT Syndrome; Morpholines; Propanolamines | 2013 |
QT dispersion after beta-blocker therapy (carvedilol or metoprolol) in children with heart failure.
Topics: Adolescent; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Child; Child Welfare; Child, Presch | 2003 |
Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy.
Topics: Adrenergic beta-Antagonists; Binding Sites; Carbazoles; Cardiovascular Diseases; Carvedilol; Cell Li | 2006 |